Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

NRX PHARMACEUTICALS, INC.

(NRXP)
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

NRX Pharmaceuticals : Partners WIth Cardinal Health For Logistics, Distribution Of Potential COVID-19 Treatment

08/26/2021 | 10:13am EDT


ę MT Newswires 2021
All news about NRX PHARMACEUTICALS, INC.
10/15RELIEF THERAPEUTICS' : COVID-19 Drug Shows Effectiveness In Open-Label Study
MT
10/15Relief Reports U.S. Collaboration Partner Announces Journal of Infectious Diseases and ..
DJ
10/14Wall Street Sees Higher Open as Bank Earnings Lift Sentiment; Jobless Claims Fall Below..
MT
10/14NRX PHARMACEUTICALS : Journal of Infectious Diseases and Treatment Publishes Positive Tria..
PR
10/14NRx Pharmaceuticals, Inc. Announces Publication of Peer-Reviewed Results from A Prospec..
CI
10/13NRX PHARMACEUTICALS : Letter to Shareholders, dated October 13, 2021 - Form 8-K
PU
10/13NRX PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
10/13Relief Reports that its U.S. Collaboration Partner has Announced Progress on Worldwide ..
DJ
10/13RELIEF THERAPEUTICS : Partner NRx Submits Revised New-Drug Module For COVID-19 Therapy; Sh..
MT
10/12NRx Pharmaceuticals Up 44% on Zyesami Progress
DJ
More news
Financials (USD)
Sales 2020 - - -
Net income 2020 -51,8 M - -
Net cash 2020 1,06 M - -
P/E ratio 2020 -
Yield 2020 -
Capitalization 552 M 552 M -
EV / Sales 2019 -
EV / Sales 2020 -
Nbr of Employees -
Free-Float 35,0%
Chart NRX PHARMACEUTICALS, INC.
Duration : Period :
NRx Pharmaceuticals, Inc. Technical Analysis Chart | NRXP | US6294441000 | MarketScreener
Technical analysis trends NRX PHARMACEUTICALS, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Managers and Directors
Jonathan C. Javitt Chairman & Chief Executive Officer
James Brandon Chief Financial Officer
Robert Besthof Chief Commercial & Patent Officer, Head-Operations
Patrick J. Flynn Independent Director
Daniel E. Troy Independent Director
Sector and Competitors
1st jan.Capi. (M$)
NRX PHARMACEUTICALS, INC.-57.95%552
MODERNA, INC.210.34%130 866
LONZA GROUP AG26.90%58 060
IQVIA HOLDINGS INC.38.89%47 683
SEAGEN INC.-1.38%31 426
CELLTRION, INC.-38.72%25 414